Medicine. The need for a global HIV vaccine enterprise
Détails
ID Serval
serval:BIB_979C680FEC57
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Medicine. The need for a global HIV vaccine enterprise
Périodique
Science
ISSN
1095-9203 (Electronic)
Statut éditorial
Publié
Date de publication
06/2003
Volume
300
Numéro
5628
Pages
2036-9
Notes
Journal Article --- Old month value: Jun 27
Résumé
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to increase the pace, reduce the overlap, and more systematically explore the elements of and delivery systems for vaccines; (iii) to use common standards for the prompt comparative testing of vaccine candidates; (iv) to expand resources for manufacturing vaccine candidates to speed their use in human trials; and (v) to increase the capacity for international clinical trials and to focus this effort toward quickly measuring the effectiveness of vaccine protection as prototype vaccine candidates are identified.
Mots-clé
*AIDS Vaccines/administration & dosage/economics/immunology
Academies and Institutes/economics/organization & administration
Biotechnology/economics
Clinical Trials/standards
Drug Design
Drug Evaluation, Preclinical/standards
Drug Industry/economics
Financial Support
HIV Infections/*prevention & control
HIV-1/*immunology
Humans
Intellectual Property
International Cooperation
Multicenter Studies
Private Sector
*Public Policy
Public Sector
Research Support
Vaccination
*World Health
Pubmed
Web of science
Création de la notice
25/01/2008 16:14
Dernière modification de la notice
20/08/2019 15:59